// App-Quantinova.ai

4089 : Natural history of patients (pts) with advanced cholangiocarcinoma (CCA) with FGFR2 gene fusion/rearrangement or wild-type (WT) FGFR2.

Researchers

Presenter

  • Rachna T. Shroff

Principal Investigators

  • Jessica Rearden

  • Ai Li

  • Susan Moran

  • Stacie Peacock Shepherd

  • Angela Lamarca

Medical Centers

  • University of Arizona Cancer Center, Tucson, AZ, QED Therapeutics Inc., San Francisco, CA

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

  • Solid malignancies

Biomarkers

  • Fibroblast growth factor receptor

  • Fibroblast Growth Factor Receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved